Franklin Resources’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,166
Closed -$1.44M 2815
2023
Q2
$1.44M Buy
14,166
+11,259
+387% +$1.15M ﹤0.01% 1515
2023
Q1
$264K Buy
+2,907
New +$264K ﹤0.01% 1904
2022
Q4
Sell
-294,889
Closed -$7.41M 2398
2022
Q3
$7.41M Sell
294,889
-338,767
-53% -$8.51M ﹤0.01% 1006
2022
Q2
$19.3M Sell
633,656
-218,502
-26% -$6.64M 0.01% 806
2022
Q1
$27.9M Sell
852,158
-105
-0% -$3.44K 0.01% 763
2021
Q4
$22.5M Sell
852,263
-172,035
-17% -$4.54M 0.01% 859
2021
Q3
$103M Sell
1,024,298
-363,662
-26% -$36.6M 0.04% 466
2021
Q2
$196M Sell
1,387,960
-71,829
-5% -$10.2M 0.08% 294
2021
Q1
$146M Sell
1,459,789
-2,138
-0.1% -$213K 0.06% 342
2020
Q4
$181M Buy
1,461,927
+68,273
+5% +$8.44M 0.08% 284
2020
Q3
$136M Buy
1,393,654
+60,573
+5% +$5.9M 0.07% 314
2020
Q2
$213M Buy
1,333,081
+131,210
+11% +$20.9M 0.11% 223
2020
Q1
$174M Sell
1,201,871
-41,260
-3% -$5.96M 0.12% 205
2019
Q4
$254M Sell
1,243,131
-11,896
-0.9% -$2.43M 0.13% 191
2019
Q3
$101M Buy
1,255,027
+96,297
+8% +$7.73M 0.05% 369
2019
Q2
$109M Buy
1,158,730
+179,994
+18% +$17M 0.06% 353
2019
Q1
$83.7M Buy
978,736
+17,437
+2% +$1.49M 0.04% 411
2018
Q4
$53.9M Buy
961,299
+102,286
+12% +$5.74M 0.03% 473
2018
Q3
$70.2M Buy
859,013
+593,552
+224% +$48.5M 0.04% 458
2018
Q2
$9.28M Buy
265,461
+27
+0% +$944 ﹤0.01% 932
2018
Q1
$5.44M Hold
265,434
﹤0.01% 1032
2017
Q4
$7.52M Buy
265,434
+15,392
+6% +$436K ﹤0.01% 998
2017
Q3
$7.78M Buy
+250,042
New +$7.78M ﹤0.01% 1004